Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Koç, D. Ediger, F. Budak, M. Karadag, B. Oral, E. Uzaslan, E. Ege, O. Gözü (Bursa, Turkey). Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients. Eur Respir J 2013; 42: Suppl. 57, 2898

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Feroptosis of alveolar macrophages in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Surfactant changes in patients with lung cancer underwent to resection Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in diagnosis of Intersticial Lung Diseases (ILD) Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue Year: 2019 Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002